Industries > Pharma > Global Wearable Injectors Market 2019-2029

Global Wearable Injectors Market 2019-2029

Global Wearable Injectors Market by Type (On-Body Injectors and Off-Body Injectors), Usage (Disposable and Semi-Reusable), Therapy (Immuno-Oncology, Diabetes, Cardiovascular Diseases and Other Therapies) and End User (Hospitals, Clinics, Home Care Settings, Ambulatory Surgery Centers and Others), Global Opportunity Analysis and Industry Forecast

PAGES: 197
PRODUCT CODE: PHA0374
SUBMARKET: Medical Devices

DOWNLOAD FREE SAMPLE
Clear
WOOCS 2.2.1
SKU: PHA0374 Categories: , Tag:

Market Definition:
• Wearable injectors is also known as bolus injectors or patch pumps are drug delivery devices specifically designed for the administration of viscous drugs at ease. These injectors are employed for s injection of insulin and other drugs subcutaneously.
• These devices are generally used for the extended delivery periods or for curing diseases that require large dose volumes. Therefore, majorly the wearable injectors are used by diabetic patients for insulin delivery and for the treatment of autoimmune diseases such as rheumatoid arthritis, psoriasis and IBD/Crohn’s disease..

Market Overview and Trends
• The growing number of biotechnology and Pharmaceutical companies that are witnessing an increasing trend of their investments for the development of different routes of administration for novel biologics and drugs specifically for subcutaneous self-administration have propelled the market growth.
• Wearable injectors bestow ease of customization as per the patient’s needs. Affluent commercialization to outfit manufacturing criteria with lower regulatory risk and ease and comfortable experience of drug delivery by patients makes it a preferred modality.
• The wearable injectors market have gained traction in the recent years owing to the benefit over other drug delivery devices like prefilled syringe is that they limit the frequency of subcutaneous injections delivered to patients.
• The wearable injectors are the new generation devices that enables reduced dosing frequency with low and acceptable pain that eventually results in enhanced patient compliance during the entire course of patient treatment especially observed in the case of diabetes patients for insulin delivery, who are dependent on long term medication.

Market Dynamics:

Factors Influencing the Market Growth:
• Growing prevalence of chronic diseases specially cancer and diabetes.
• Emergence of novel and technologically advanced wearable injectors in the market.
• The growing advent of self-injection devices, over the decade especially lays emphasis on the emergence of convenient, patient-centric, user-friendly and cost-effective wearable drug delivery devices have added boost to the market growth.
• Favorable reimbursement scenario in the key markets.

Factors Restraining the Market Growth:
• Presence of substitute or preference for alternative mode of drug delivery.

Market Segmentation 2019-2029:

Type
• On-body injectors Market, 2019-2029
• Off-body injectors Market, 2019-2029

Usage
• Disposable Market, 2019-2029
• Semi-Reusable Market, 2019-2029

Therapy
• Immuno-oncology Market, 2019-2029
• Diabetes Market, 2019-2029
• Cardiovascular Diseases Market, 2019-2029
• Other Therapies (Parkinson’s disease, Thalassemia, and Primary Immunodeficiency Disorders) Market, 2019-2029

End User
• Hospitals Market, 2019-2029
• Clinics Market, 2019-2029
• Home Care Settings Market, 2019-2029
• Ambulatory Surgery Centres Market, 2019-2029
• Others Market, 2019-2029

Geographic breakdown
Focused regional forecasts and analysis explore the future opportunities:

• North America Market, 2019-2029
– U.S. Market, 2019-2029
– Canada Market, 2019-2029
– Mexico Market, 2019-2029
– Rest of North America Market, 2019-2029

• Europe Market, 2019-2029
– Germany Market, 2019-2029
– UK Market, 2019-2029
– France Market, 2019-2029
– Spain Market, 2019-2029
– Italy Market, 2019-2029
– Rest of Europe Market, 2019-2029

• Asia-Pacific Market, 2019-2029
– China Market, 2019-2029
– Japan Market, 2019-2029
– India Market, 2019-2029
– Australia Market, 2019-2029
– Malaysia Market, 2019-2029
– Rest of Asia Pacific Market, 2019-2029

• LAMEA Market, 2019-2029
– Brazil Market, 2019-2029
– Argentina Market, 2019-2029
– Turkey Market, 2019-2029
– South Africa Market, 2019-2029
– Rest of LAMEA Market, 2019-2029

Competitive Analysis:
• There are many companies operating in the market, however, number of players are entering in the market by developing more standardized and cost effective products.
• Companies are strategically expanding their global presence and offering improved products across various sectors.

Major Market Players:
• Amgen, Medtronic PLC, Insulet Corporation, Ypsomed, Becton, Dickinson and Company, Tandem Diabetes Care, Inc., United Therapeutics Corporation, Valeritas, Inc., Enable Injections, Steadymed Therapeutics and Sensile Medical (A Part of Gerresheimer)

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Wearable Injectors Market 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Global Wearable Injectors Market 2019-2029


Latest Pharma news

Visiongain Publishes Biological API Manufacturing Services Market Report 2021-2031

Demand in the early years of the forecast period will come from multinational biotech looking to sign deals with Indian companies and take advantage of the cheaper costs of production for the emerging market.

08 January 2021

READ

Visiongain Publishes Anaesthesia & Respiratory Devices Market Report 2020-2030

The growth can be attributed to the rising prevalence of respiratory diseases, growing awareness for respiratory diseases, and innovations in respiratory and anesthesia devices. However, unfavourable reimbursement policies and lack of patient adherence in respiratory diseases are some of the factors restraining the growth of the anesthesia and respiratory devices market.

07 January 2021

READ

Visiongain Publishes Inactivated Vaccines Market Report 2020-2030

Factors such as rise in the prevalence of the infectious and bacterial diseases and active participation of government in vaccine development are driving the growth of this market. While high cost of vaccine development is the key factor emerging as a growth barrier over years in this market.

07 January 2021

READ

Visiongain Publishes Human Microbiome Therapeutics Market Report 2021-2031

The potential of microbiome-based drugs as novel treatments to address the unmet needs for many diseases has contributed intensively to the rapid emergence of many investors in this area. Currently, no regulatory framework exists and no drugs have received FDA approval. However, there are several preclinical and clinical-stage companies working with various approaches to develop microbiome-based therapies.

06 January 2021

READ

Categories

Category